BNP Paribas Financial Markets
BIND

BNP Paribas Financial Markets’s BIND THERAPEUTICS INC BIND Stock Holding History

BNP Paribas Financial Markets’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-324
Closed -$2.78K – 4138
2014
Q3 		$2.78K Hold
324
– – ﹤0.01% 3907
2014
Q2 		$4.27K Buy
324
+299
+1,196% +$2.93K ﹤0.01% 2669
2014
Q1 		$236 Buy
+25
New +$326 ﹤0.01% 3185

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BNP Paribas Financial Markets's BIND Position: Q4 2014 in Review

BNP Paribas Financial Markets sold out of BIND THERAPEUTICS INC (BIND) in Q4 2014, closing a stake of 324 shares — an estimated $2.78K sold.

BNP Paribas Financial Markets first reported a position in BIND in Q1 2014 and held it in 3 quarters. The position peaked at $4.27K in Q2 2014. 37 funds tracked by Wall St. Rank hold BIND as of Q4 2014.

  • BNP Paribas Financial Markets reported no remaining BIND THERAPEUTICS INC position as of Q4 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 324 BIND THERAPEUTICS INC shares in Q4 2014, an estimated $2.78K.
  • BNP Paribas Financial Markets first reported a position in BIND THERAPEUTICS INC in Q1 2014 and held it in 3 quarters.
  • BNP Paribas Financial Markets's BIND THERAPEUTICS INC position peaked at $4.27K in Q2 2014.
  • 37 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2014, filed 11 Feb 2015.